I evaluated a semi-automated method for measuring glycohemoglobin via reduction of nitroblue tetrazolium by acetoneextracted globin. The simultaneous measurement of glycated protein and total protein with the Roche Mira S analyzer showed good analytical precision (between-batch CV 3.5%-8.5%). Correlation of results (y with those by a boronate affinity chromatography method (x) gave a regression line of y = 2.Ox + 5.9 for samples from patients attending a diabetic outpatient clinic. I also studied reaction kinetics; chioromercuribenzoate concentration, sample volume, and detergent concentration affect the reaction, probably by modulating the reduction of dye by globin-thiol groups. Recently, Somarn et al.
The analyzer protocol involved pipetting into the reaction cuvette 85 L of globin solution with 10 pL of water, followed by 85 jL of diluent reagent and 95 pL of dye reagent. The change in absorbance between 10 and 15 mm after mixing was recorded. All incubations were conducted at 37 #{176}C.
To perform the assay, collect samples of whole blood into EDTA tubes by vempuncture, and store specimens at 4#{176}C. Add 0.1 mL of whole blood to 10 mL of 0.9 g/L sodium chloride reagent and mix the cell suspension well. After centrifugation, discard the supernate and add 1 mL of distilled water to the cell pellet. Vortex-mix, then let the hemolysate stand for 15 mm. After further centrifugation, slowly add 1 mL of supernate to 10 mL of ice-cold acetone containing 50 L of 1 mol/L hydrochloric acid reagent. Mix the solution, let it stand for 30 mm, then centrifi.ige the tubes for 10 mm at 1000 x g. Discard the supernate and immediately redissolve the precipitated globin in 0.5 mL of 0.9 g/L sodium chloride solution.
Throughout the study, I used pooled human serum diluted 10-fold and fivefold with 0.9 g/L NaCl solution as the glycated globin and total globin calibrators, respectively. Glycated globin values were assigned to the calibrators by assaying against deoxymorpholinofructose, and were expressed as millimoles of glycated globin per gram of hemoglobin. Globin concentration was measured by a biuret method on the Mira S simultaneously with glycated globin, as follows. Globin extract (40 /.LL) was added to 250 .tL of biuret reagent, which contained, per liter, 14.3 mmol of copper sulfate, 38 mmol of potassium sodium tartrate, 36 mmol/L of potassium iodide, and 700 mmol of sodium hydroxide.
Hemoglobin (A, fraction; HbA1) was measured by boronate affinity chromatography (Pierce and Warriner, Chester, Cheshire, U.K.). The leukocyte count was determined with a Symex K 1000 counter (Toa Medical Electronics, Kobe, Japan).
Results
Solubility of globin in assay reagents. The changes in absorbance that occurred during the 15-mm period after adding extracted globin to the initial reagent system are shown in Figure 1 . A rapid increase in absorbance was followed by a plateau, during which absorbance changed very little. After 15 mm, a white precipitate, presumed to no added When no pre-incubation period was used and absorbance changes were read over the first 5 mm of reaction, the correlation was poor Increasing pre-incubation time to 10 mm followed by a 5-min read time produced similar good correlation (r = 0.97), with RER = 1.58 and the regression equation being y = 2.Ox + 5.9.
Precision. The precision of the method was assessed by taking fresh blood samples from individual diabetic patients through the entire extraction and measurement procedure. Table 1 shows the within-run and between-run precision.
Linearity. With a globin solution diluted as described in Reducing compounds in serum, e.g., ascorbate and urate, which might interfere with NBT reduction, were removed during the saline wash step, which dilutes plasma 100-fold.
To test the effect of high concentrations of ascorbate, I
added 100 jL of a 50 mg/L solution of ascorbic acid to 100
L of blood and compared the result for this with that for a control containing no ascorbic acid. The recovery of glycated globin in the supplemented sample was <3% more than that of the control. I conclude that extracellular lowmolecular-mass compounds are unlikely to interfere with this method. To test the effect of urate, I added 50 L of serum from a patient with renal failure (urate concentration 717 pmol/L) to triplicate samples of blood, but found no detectable interference. Stability and storage. Extracted globin was stable in saline solution at room temperature for at least 12 h. HbA1 in whole blood is stable for at least one week. Hemolysates of erythrocytes may be stored up to one month at -20 #{176}C.
Discussion
Although this method requires preparation of globin before automated analysis, the preparation stage is simple and contains no critical steps that require accurate measurements. A sample processor capable of fast liquid handling can reduce technician time to <1 h, comparable with that of other methods for HbA1 analysis, e.g., affinity chromatography.
Results by this method correlate well with those by affinity chromatography and show a magnitude of intercept similar to that seen in comparisons between affinity chromatography and another chemical method (5) (thiobarbituric acid) . However, Somani et al. (2) reported a negligible intercept in a similar comparison of affinity chromatography and a manual NBT method (2). The presence of an intercept on the dilution curve requires further investigation.
Adding detergent to alkaline reduction methods for glycated protein has previously been shown to be beneficial for the assay system (6) . In this case, adding detergent ensures solubility of extracted globin.
Dye-reduction methods for glycated proteins have until recently been calibrated against deoxymorpholinofructose. The shortcomings of this material as a calibrant have been discussed elsewhere (7) . Glycated polylysine has been suggested as a suitable alternative (8) . Another approach would be to calibrate the glycated globin assay via a well-validated method for HbA1 (e.g., affinity chromatography) or HbA1C (e.g., HPLC). The disadvantage is that methods based on different principles measure different proportions of the glycohemoglobin subclasses.
This method appears to be worthy of further development; however, larger clinical studies are required before the assay can be recommended as a routine test.
